Search Results - "Gustafson, Thomas" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

MBX-102/JNJ39659100, a Novel Peroxisome Proliferator-Activated Receptor-Ligand with Weak Transactivation Activity Retains Antidiabetic Properties in the Absence of Weight Gain and Edema

MBX-102/JNJ39659100, a Novel Peroxisome Proliferator-Activated Receptor-Ligand with Weak Transactivation Activity Retains Antidiabetic Properties in the Absence of Weight Gain and Edema

by Gregoire, Francine M, Zhang, Fang, Clarke, Holly J, Gustafson, Thomas A, Sears, Dorothy D, Favelyukis, Svetlana, Lenhard, James, Rentzeperis, Dennis, Clemens, L. Edward, Mu, Yi, Lavan, Brian E
Published in Molecular endocrinology (Baltimore, Md.) (01.07.2009)

Get full text

Journal Article

Halofenate is a selective peroxisome proliferator-activated receptor [gamma] modulator with antidiabetic activity

Halofenate is a selective peroxisome proliferator-activated receptor [gamma] modulator with antidiabetic activity

by Allen, Tamara, Zhang, Fang, Moodie, Shonna A, Clemens, L. Edward, Smith, Aaron, Gregoire, Francine, Bell, Andrea, Muscat, George E.O, Gustafson, Thomas A
Published in Diabetes (New York, N.Y.) (01.09.2006)

Get full text

Journal Article

Halofenate Is a Selective Peroxisome Proliferator–Activated Receptor γ Modulator With Antidiabetic Activity

Halofenate Is a Selective Peroxisome Proliferator–Activated Receptor γ Modulator With Antidiabetic Activity

by ALIEN, Tamara, FANG ZHANG, MOODIE, Shonna A, CLEMENS, L. Edward, SMITH, Aaron, GREGOIRE, Francine, BELL, Andrea, MUSCAT, George E. O, GUSTAFSON, Thomas A
Published in Diabetes (New York, N.Y.) (01.09.2006)

Get full text

Journal Article

Oncology Care in 2021: the FDA, Medicare, and healthcare reform

Oncology Care in 2021: the FDA, Medicare, and healthcare reform

by Gottlieb, Scott, Gustafson, Thomas A, Johnson, Daniel H
Published in Oncology (Williston Park, N.Y.) (15.05.2011)

Get full text

Journal Article

MBX-102/JNJ39659100, a Novel Peroxisome Proliferator Activated Receptor-γ Ligand with Weak Transactivation Activity Retains Full Anti-Diabetic Properties in the Absence of Side Effects

MBX-102/JNJ39659100, a Novel Peroxisome Proliferator Activated Receptor-γ Ligand with Weak Transactivation Activity Retains Full Anti-Diabetic Properties in the Absence of Side Effects

by Gregoire, Francine M, Zhang, Fang, Clarke, Holly J, Gustafson, Thomas A, Sears, Dorothy D, Favelyukis, Svetlana, Lenhard, James, Rentzeperis, Dennis, Clemens, L. Edward, Mu, Yi, Lavan, Brian E
Published in Endocrine reviews (01.06.2009)

Get full text

Journal Article

14-3-3 (Ïµ) Interacts with the Insulin-like Growth Factor I Receptor and Insulin Receptor Substrate I in a Phosphoserine-dependent Manner

14-3-3 (Ïµ) Interacts with the Insulin-like Growth Factor I Receptor and Insulin Receptor Substrate I in a Phosphoserine-dependent Manner

by Craparo, A, Freund, R, Gustafson, T A
Published in The Journal of biological chemistry (25.04.1997)

Get full text

Journal Article

Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain

Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain

by Nelms, Keats, O'Neill, Thomas J, Li, Shiqing, Hubbard, Stevan R, Gustafson, Thomas A, Paul, William E
Published in Mammalian genome (01.12.1999)

Get full text

Journal Article

Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin

Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin

by Bandyopadhyay, Debdutta, Kusari, Anasua, Kenner, Kathleen A., Liu, Feng, Chernoff, Jonathan, Gustafson, Thomas A., Kusari, Jyotirmoy
Published in The Journal of biological chemistry (17.01.1997)

Get full text

Journal Article

The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors

The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors

by Stein, Evan G., Gustafson, Thomas A., Hubbard, Stevan R.
Published in FEBS letters (30.03.2001)

Get full text

Journal Article

392-P: Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus

392-P: Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus

by GAICH, GREGORY, BILIC, SANELA, DAGON, YOSSI, GUSTAFSON, THOMAS, LAWLER, JOHN, JOHNSON, LESLIE, RUDOLPH-OWEN, LORI
Published in Diabetes (New York, N.Y.) (01.06.2022)

Get full text

Journal Article

Identification of the APS Protein as a Novel Insulin Receptor Substrate

Identification of the APS Protein as a Novel Insulin Receptor Substrate

by Moodie, S A, Alleman-Sposeto, J, Gustafson, T A
Published in The Journal of biological chemistry (16.04.1999)

Get full text

Journal Article

Grb10 Interacts Differentially with the Insulin Receptor, Insulin-like Growth Factor I Receptor, and Epidermal Growth Factor Receptor via the Grb10 Src Homology 2 (SH2) Domain and a Second Novel Domain Located between the Pleckstrin Homology and SH2 Domains

Grb10 Interacts Differentially with the Insulin Receptor, Insulin-like Growth Factor I Receptor, and Epidermal Growth Factor Receptor via the Grb10 Src Homology 2 (SH2) Domain and a Second Novel Domain Located between the Pleckstrin Homology and SH2 Domains

by He, W, Rose, D W, Olefsky, J M, Gustafson, T A
Published in The Journal of biological chemistry (20.03.1998)

Get full text

Journal Article

Leveraging High-Content Imaging Platforms for Drug Discovery: PO2504

Leveraging High-Content Imaging Platforms for Drug Discovery: PO2504

by Pan, Xiang, Norman, Timothy A., Fanelli, Alyssa, Gallagher, Justin A., Kyrychenko, Sergii, Gallagher, Rachel, Gustafson, Thomas A., Lalioti, Maria
Published in Journal of the American Society of Nephrology (01.10.2021)

Get full text

Journal Article

Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (∗)

Non-SH2 Domains within Insulin Receptor Substrate-1 and SHC Mediate Their Phosphotyrosine-dependent Interaction with the NPEY Motif of the Insulin-like Growth Factor I Receptor (∗)

by Craparo, Ann, O'Neill, Thomas J., Gustafson, Thomas A.
Published in The Journal of biological chemistry (30.06.1995)

Get full text

Journal Article

A Highly Efficient and Reproducible Differentiation Protocol for Induced Pluripotent Stem Cell-Derived Podocytes: PO1679

A Highly Efficient and Reproducible Differentiation Protocol for Induced Pluripotent Stem Cell-Derived Podocytes: PO1679

by Kyrychenko, Sergii, Gallagher, Justin A., Norman, Timothy A., Fanelli, Alyssa, Pan, Xiang, Fast, Eva, Gallagher, Rachel, Gustafson, Thomas A., Lalioti, Maria
Published in Journal of the American Society of Nephrology (01.10.2021)

Get full text

Journal Article

Synthesis of an organoinsulin molecule that can be activated by antibody catalysis

Synthesis of an organoinsulin molecule that can be activated by antibody catalysis

by Worrall, D S, McDunn, J E, List, B, Reichart, D, Hevener, A, Gustafson, T, Barbas, 3rd, C F, Lerner, R A, Olefsky, J M
Published in Proceedings of the National Academy of Sciences - PNAS (20.11.2001)

Get full text

Journal Article

The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation

The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation

by Taylor, A, Webster, K A, Gustafson, T A, Kedes, L
Published in Molecular and cellular biochemistry (01.04.1997)

Get full text

Journal Article

Distinct Modes of Interaction of SHC and Insulin Receptor Substrate-1 with the Insulin Receptor NPEY Region via Non-SH2 Domains (∗)

Distinct Modes of Interaction of SHC and Insulin Receptor Substrate-1 with the Insulin Receptor NPEY Region via Non-SH2 Domains (∗)

by He, Weimin, O'Neill, Thomas J., Gustafson, Thomas A.
Published in The Journal of biological chemistry (06.10.1995)

Get full text

Journal Article

OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus

OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus

by Bilic, Sanela, Dagon, Yossi, Gustafson, Thomas, Johnson, Leslie, Lawler, John, Rudolph-Own, Lori, Gaich, Gregory, Tucker, Edwin
Published in Journal of the Endocrine Society (01.11.2022)

Get full text

Journal Article

Interaction of MAD2 with the Carboxyl Terminus of the Insulin Receptor but Not with the IGFIR EVIDENCE FOR RELEASE FROM THE INSULIN RECEPTOR AFTER ACTIVATION

Interaction of MAD2 with the Carboxyl Terminus of the Insulin Receptor but Not with the IGFIR EVIDENCE FOR RELEASE FROM THE INSULIN RECEPTOR AFTER ACTIVATION

by O'Neill, T J, Zhu, Y, Gustafson, T A
Published in The Journal of biological chemistry (11.04.1997)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[12]